Development of AVIPure® - AAV9: The first highly reusable AAV affinity resin with NaOH cleaning capabilities
High doses of AAV are becoming increasingly common in gene therapies. In order to meet the growing and ever-changing needs of the biopharmaceutical industry, Avitide has developed the world's first highly reusable affinity chromatography resin with sodium hydroxide (NaOH) cleaning capabilities - AVIPure® - AAV9.

Thomas Scanlon, Ph.D.
Director of Ligand Discovery
Join Tom Scanlon, PhD, Director of Ligand Discovery at Avitide as he discusses Avitide’s affinity resin development platform, AVIPure® - AAV9 Development, and market drivers for AAV resin reuse.
AVIPure® - AAV9 resin is manufactured on site at Avitide headquarters in Lebanon, New Hampshire and is AVAILABLE NOW for commercial manufacturing applications.

16 Cavendish Court
Lebanon, NH 03766
603.965.2100
email us
Subscribe to hear the latest news and insights…